The National Institutes of Health (NIH) announced it is expected to award up to $70 million over five years to three physician-scientists to launch the Alzheimer's Clinical Trials Consortium (ACTC). The consortium will create a network of 35 Alzheimer's disease trial sites across the country with the goal of finding new ways to treat or prevent Alzheimer's. Reisa Sperling, MD, director of the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital, will collaborate with
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
LabCorp Forms Strategic Partnership with MC10 to Support Adoption of BioStamp Sensor
Global life sciences company LabCorp has formed a strategic collaboration with MC10, a digital health startup developing wearable sensor systems for seamless healthcare data collection. As part of the strategic partnership, LabCorp has also made an equity investment into MC10 to support adoption of it’s proprietary technology for use by LabCorp’s Covance Drug Development business in clinical trials and research studies, with the potential to be adapted over time for use in patient testing and
Read More
Bracket Acquires Mobile Patient Engagement Tool for Clinical Trials Provider mProve Health
Bracket, a provider of clinical trial technology and specialty services provider has acquired mProve Health Inc., a provider of mobile patient engagement tools for clincial trials to support life sciences companies. For Bracket, the acquisition will help improve patient engagement through the use of "Bring Your Own Device" mobile tools in clinical trials.Founded in 2010, mProve offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and
Read More
Aurora Cancer Care Launches Precision Medicine Program To Help Patients Gain More Access to Clinical Trials
Aurora Cancer Care, a not-for-profit health care provider in Wisconsin and northern Illinois is launching a precision medicine program powered by Syapse, a provider of precision oncology solutions. The new oncology precision medicine program will help physicians and researchers provide more care options for patients whose cancer is resistant to conventional treatment options like radiation and chemotherapy.The new multi-disciplinary Oncology Precision Medicine Clinic will be located inside
Read More
Median Technologies and inVentiv Health Partner to Provide Medical Image Analysis for Clinical Trials
Median Technologies, the Imaging Phenomics Company, and inVentiv Health, a biopharmaceutical professional services company, announced a strategic alliance to offer biopharmaceutical clients with best-in-class medical image analysis and management services for early to late stage oncology clinical trials. The alliance will provide inVentiv clients with the most advanced imaging biomarkers, at a time when 73 percent of cancer compounds in clinical trials involve biomarkers in their research and
Read More
Comprehend Systems Lands $15M to Expand Clinical Trials Data Platform
Comprehend Systems, Inc., a provider of Clinical Intelligence solutions has raised $15 million in Series C funding led by Eminence Capital, with participation by existing investors Sequoia Capital and Lightspeed Venture Partners.The company plans to utilize the funding to aggressively expand sales and engineering to meet a growing demand for Comprehend's cloud-based software that enables Clinical Research teams to deliver an order of magnitude improvement in the speed and quality of trial
Read More
DrFirst Acquires VisibilityRx to Optimize Clinical Trial Recruitment
DrFirst, a provider of electronic prescribing, integrated medication management and secure communication for healthcare has acquired Duluth, GA-based VisibilityRx, a provider of clinical trial recruitment services to life sciences, clinical research organizations and pharmacies. Financial terms of the acquisition were not disclosed. For DrFirst, the acquisition provides 60,000 physician clients the ability to easily identify and refer their patients to the latest clinical trials and
Read More
Specimatch Launches Clinical Trial Monitoring Platform for Cancer Patients
Specimatch, a continual clinical trial monitoring service, has unveiled the web-based software service for cancer patients and oncologists. On Specimatch.com, users can easily and intuitively connect to clinical trials personally matched to the patient’s genetic and clinical profiles.Founded in 2016 by Dr. Ken Dixon, founder/surgical oncologist of Surgical Oncologists of Northeast Georgia, Specimatch.com’s interface was created to let both clinicians and patients take part in the management of
Read More
Philips, N-of-One Partner to Speed Clinical Interpretation of Cancer Genomics
Royal Philips and N-of-One, Inc., a provider of clinical interpretation of molecular tests in oncology is teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips’ new precision medicine solution for oncology.This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with
Read More
American Heart Association, Amazon Launch Cloud-Based Precision Medicine Data Marketplace
The American Heart Association (AHA) has announced a strategic collaboration with Amazon Web Services (AWS) to launch a secure cloud-based precision medicine data marketplace. The marketplace will include a vast array of curated rich datasets, that are centrally stored, easily searched and accessible, and managed on the AWS cloud. This platform enables researchers and clinicians to aggregate and analyze a rich breadth and depth of data including longitudinal cohorts, proteomic, genomic, and
Read More
